Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden
· Delayed Price · Currency is SEK 3.140
+0.030 (0.96%)
Apr 28, 2026, 5:24 PM CET
375.76% (1Y)
| Market Cap | 331.32M |
| Revenue (ttm) | 167.39M |
| Net Income (ttm) | 91.74M |
| Shares Out | 105.52M |
| EPS (ttm) | 0.98 |
| PE Ratio | 3.20 |
| Forward PE | 17.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 241,795 |
| Average Volume | 1,021,330 |
| Open | 3.100 |
| Previous Close | 3.110 |
| Day's Range | 3.020 - 3.260 |
| 52-Week Range | 0.360 - 4.140 |
| Beta | -0.72 |
| RSI | 56.36 |
| Earnings Date | May 8, 2026 |